https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

HPTN 052: No HIV Transmissions on Effective Antiretroviral Therapy but Only Limited Data on Viral Failure and Drug Resistance Img

HPTN 052: No HIV Transmissions on Effective Antiretroviral Therapy but Only Limited Data on Viral Failure and Drug Resistance

Although finding no linked transmissions is clearly important and impressive, it is unclear why the extremely limited data on viral failure has been held back for so long.

Promo Image

What's the Next Big Question in HIV Treatment?

Now that a major study has concluded that the benefits of starting treatment immediately far outweighs the risks of delaying for all individuals living with HIV – what’s the next big question researchers should try to answer about HIV treatment?

HIV Antiretroviral Study Highlights From IAS 2015 Img

HIV Antiretroviral Study Highlights From IAS 2015

We briefly summarize some of the most noteworthy new HIV treatment studies presented at a major research conference that took place this month.

WHO Testing Guidelines Tackle the Most Problematic 90 of 90-90-90 With Look at Strategies Img

WHO Testing Guidelines Tackle the Most Problematic 90 of 90-90-90 With Look at Strategies

WHO releases 2015 Consolidated Guidelines on HIV Testing Services with five Cs: consent, confidentiality, counselling, correct results and connection.

WHO 2015 Guidelines to Recommend Treatment for All HIV-Positive People Img

WHO 2015 Guidelines to Recommend Treatment for All HIV-Positive People

Gottfried Hirnschall, Director of HIV Department at World Health Organization (WHO), provided a "sneak preview" of the in-the-process-of-being-updated 2015 consolidated guidelines.

Pharmacokinetics of Antiretrovirals in Pregnancy: Rilpivirine, Etravirine and Raltegravir Img

Pharmacokinetics of Antiretrovirals in Pregnancy: Rilpivirine, Etravirine and Raltegravir

Three posters at CROI 2015 described pharmacokinetics of antiretrovirals in pregnancy for rilpivirine, etravirine and raltegravir. None of the studies suggested that dose adjustment is required.

CROI 2015: Update on HIV Treatment Research (Video) Img

CROI 2015: Update on HIV Treatment Research (Video)

To provide an update on the latest antiretroviral treatment research, Fred Schaich of IFARA spoke with Joel Gallant, M.D., of the Southwest Care Center.

Dosing Regimen of 5 Days On and 2 Days Off Controls HIV in Young People Img

Dosing Regimen of 5 Days On and 2 Days Off Controls HIV in Young People

A study showed viral control in the great majority of youth who took their regimen for five days but then skipped two, which may offer younger patients a novel way to keep HIV under control while addressing common adherence issues.

Promo Image

What 2014 Development Has the Biggest Impact on HIV Care?

Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …

Promo Image

HIV Drug Development Pipeline Update, Fall 2014 Edition

HIV treatment remains far from perfect, and there are still seats at the table available for improved antiretrovirals. Paul Sax, M.D., provides an update on several of the most noteworthy candidates currently in development.